Summary by Moomoo AI
Shanghai Fosun Pharma Group Co., Ltd. (referred to as "Fosun Pharma") announced on November 8, 2024 that its holding subsidiary provided guarantees for the debts under the financing of related holding subsidiaries. Specifically, Fosun Diagnostic Technology (Shanghai) Co., Ltd. ("Fosun Diagnostics") provided guarantees for the financing not exceeding RMB 150 million applied by its holding subsidiary, Fosun Diagnostic Technology (Changsha) Co., Ltd. ("Fosun Diagnostics Changsha"), to bank of changsha, as well as three other guarantee cases. As of November 7, 2024, including this guarantee, the actual external guarantee amount of Fosun Pharma Group is approximately RMB 30,750.95 million, accounting for approximately 67.31% of the net assets attributable to shareholders of the listed company audited by the 2023. This guarantee was carried out within the approved guarantee limit at the 2023 shareholder meeting, and the board of directors believes that the guarantee is based on the operational needs of the group, and the risks are relatively controllable.
